These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 3031162

  • 1. HTLV-III large envelope protein (gp120) suppresses PHA-induced lymphocyte blastogenesis.
    Mann DL, Lasane F, Popovic M, Arthur LO, Robey WG, Blattner WA, Newman MJ.
    J Immunol; 1987 Apr 15; 138(8):2640-4. PubMed ID: 3031162
    [Abstract] [Full Text] [Related]

  • 2. HLA-DR is involved in the HIV-1 binding site on cells expressing MHC class II antigens.
    Mann DL, Read-Connole E, Arthur LO, Robey WG, Wernet P, Schneider EM, Blattner WA, Popovic M.
    J Immunol; 1988 Aug 15; 141(4):1131-6. PubMed ID: 2840463
    [Abstract] [Full Text] [Related]

  • 3. Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding.
    Clayton LK, Sieh M, Pious DA, Reinherz EL.
    Nature; 1989 Jun 15; 339(6225):548-51. PubMed ID: 2543930
    [Abstract] [Full Text] [Related]

  • 4. HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infection.
    Weinhold KJ, Lyerly HK, Stanley SD, Austin AA, Matthews TJ, Bolognesi DP.
    J Immunol; 1989 May 01; 142(9):3091-7. PubMed ID: 2468713
    [Abstract] [Full Text] [Related]

  • 5. Characterization of CD4 glycoprotein determinant-HIV envelope protein interactions: perspectives for analog and vaccine development.
    Farrar WL, Harel-Bellan A, Ferris DK.
    Crit Rev Immunol; 1988 May 01; 8(4):315-39. PubMed ID: 2850890
    [Abstract] [Full Text] [Related]

  • 6. Envelope glycoproteins of HIV-1 interfere with T-cell-dependent B cell differentiation: role of CD4-MHC class II interaction in the effector phase of T cell help.
    Chirmule N, Wang XP, Hu R, Oyaizu N, Roifman C, Pahwa R, Kalyanaraman VS, Pahwa S.
    Cell Immunol; 1994 Apr 15; 155(1):169-82. PubMed ID: 8168144
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of CD4+ T cell function by the HIV envelope protein, gp120.
    Diamond DC, Sleckman BP, Gregory T, Lasky LA, Greenstein JL, Burakoff SJ.
    J Immunol; 1988 Dec 01; 141(11):3715-7. PubMed ID: 2846691
    [Abstract] [Full Text] [Related]

  • 8. A soluble CD4 protein selectively inhibits HIV replication and syncytium formation.
    Hussey RE, Richardson NE, Kowalski M, Brown NR, Chang HC, Siliciano RF, Dorfman T, Walker B, Sodroski J, Reinherz EL.
    Nature; 1988 Jan 07; 331(6151):78-81. PubMed ID: 2829023
    [Abstract] [Full Text] [Related]

  • 9. Soluble CD4 molecules neutralize human immunodeficiency virus type 1.
    Traunecker A, Lüke W, Karjalainen K.
    Nature; 1988 Jan 07; 331(6151):84-6. PubMed ID: 2829024
    [Abstract] [Full Text] [Related]

  • 10. Identification of nanopeptide from HTLV-III, ARV-2 and LAVBRU envelope gp120 determining binding to T4 cell surface protein.
    Veljković V, Metlas R.
    Cancer Biochem Biophys; 1988 Nov 07; 10(2):91-106. PubMed ID: 2855309
    [Abstract] [Full Text] [Related]

  • 11. [HIV envelope proteins are bound by human epidermal Langerhans cells by a binding site which differs from the site on the CD4 molecule, and are internalized by receptor endocytosis].
    Schmitt D, Dezutter-Dambuyant C, Hanau D, Schmitt DA, Kolbe HV, Kieny MP, Cazenave JP, Thivolet J.
    C R Acad Sci III; 1989 Nov 07; 308(10):269-75. PubMed ID: 2543485
    [Abstract] [Full Text] [Related]

  • 12. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71).
    Chirmule N, McCloskey TW, Hu R, Kalyanaraman VS, Pahwa S.
    J Immunol; 1995 Jul 15; 155(2):917-24. PubMed ID: 7541827
    [Abstract] [Full Text] [Related]

  • 13. HIV infection is blocked in vitro by recombinant soluble CD4.
    Fisher RA, Bertonis JM, Meier W, Johnson VA, Costopoulos DS, Liu T, Tizard R, Walker BD, Hirsch MS, Schooley RT.
    Nature; 1988 Jan 07; 331(6151):76-8. PubMed ID: 2829022
    [Abstract] [Full Text] [Related]

  • 14. HIV type 1 envelope glycoprotein 120 carboxy-terminal peptide-induced human T cell lines selectively suppress heterogeneous proliferative T cell responses to soluble antigens.
    Wilson SE, Habeshaw JA, Addawe MA, Hounsell EF, Oxford JS.
    AIDS Res Hum Retroviruses; 1997 Oct 10; 13(15):1313-24. PubMed ID: 9339848
    [Abstract] [Full Text] [Related]

  • 15. A soluble form of CD4 (T4) protein inhibits AIDS virus infection.
    Deen KC, McDougal JS, Inacker R, Folena-Wasserman G, Arthos J, Rosenberg J, Maddon PJ, Axel R, Sweet RW.
    Nature; 1988 Jan 07; 331(6151):82-4. PubMed ID: 3257544
    [Abstract] [Full Text] [Related]

  • 16. Alternative pathway of complement activation by stimulated T lymphocytes. I. Binding of C3 fragments.
    Sármay G, Ramos OF, Klein E, Kai C, Gergely J.
    Eur J Immunol; 1987 Jul 07; 17(7):969-74. PubMed ID: 3111862
    [Abstract] [Full Text] [Related]

  • 17. Immunomodulatory role of thyroid hormones: in vitro effect of tetraiodothyronine (T4) on mitogen induced blastogenic response of lymphocytes.
    Chandel AS.
    Indian J Exp Biol; 1990 Apr 07; 28(4):322-5. PubMed ID: 2351415
    [Abstract] [Full Text] [Related]

  • 18. Cyclosporin A does not prevent expression of Tac antigen, a probable TCGF receptor molecule, on mitogen-stimulated human T cells.
    Miyawaki T, Yachie A, Ohzeki S, Nagaoki T, Taniguchi N.
    J Immunol; 1983 Jun 07; 130(6):2737-42. PubMed ID: 6406595
    [Abstract] [Full Text] [Related]

  • 19. Receptor molecule blocks HIV.
    Weiss RA.
    Nature; 1988 Jan 07; 331(6151):15. PubMed ID: 2829021
    [No Abstract] [Full Text] [Related]

  • 20. Lymphocyte activation by HIV-1 envelope glycoprotein.
    Kornfeld H, Cruikshank WW, Pyle SW, Berman JS, Center DM.
    Nature; 1988 Sep 29; 335(6189):445-8. PubMed ID: 2843775
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.